COCP (Cocrystal Pharma) OCF Yield %: -54.53 (As of Jun. 26, 2026)


COCP Cocrystal Pharma Inc COCP
25 GF Score
Price $1.01
! 3 Warning Signs
View Full Analysis

What is Cocrystal Pharma OCF Yield %?

Cocrystal Pharma COCP -3.35% 25 OCF Yield % is -54.53 as of Jun. 26, 2026. GuruFocus rates COCP with a GF Score™ of 25/100. The stock has 3 warning signs investors should review. Among 1,419 Biotechnology companies, Cocrystal Pharma ranks worse than 84.5% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Cocrystal Pharma's Trailing 12-Month Cash Flow from Operations is $-7.59 Mil, and Market Cap is $13.93 Mil. Therefore, Cocrystal Pharma's OCF Yield % for today is -54.53%.

The historical rank and industry rank for Cocrystal Pharma's OCF Yield % or its related term are showing as below:

COCP' s OCF Yield % Range Over the Past 10 Years
Min: -165.95   Med: -21.04   Max: -3.47
Current: -54.53


During the past 13 years, the highest OCF Yield % of Cocrystal Pharma was -3.47%. The lowest was -165.95%. And the median was -21.04%.

COCP's OCF Yield % is ranked worse than
84.5% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs COCP: -54.53

Cocrystal Pharma's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Cocrystal Pharma OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Cocrystal Pharma OCF Yield % Related Terms


Cocrystal Pharma OCF Yield % Historical Data

* Premium members only.

The historical data trend for Cocrystal Pharma's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cocrystal Pharma OCF Yield % Chart

Cocrystal Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.08 -134.99 -83.70 -80.21 -60.71

Cocrystal Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -81.37 -56.86 -33.42 -51.46 -67.22

COCP vs OSRH, CVKD, LEXX: OCF Yield % Comparison

For the Biotechnology subindustry, Cocrystal Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cocrystal Pharma OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cocrystal Pharma's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Cocrystal Pharma's OCF Yield % falls into.


COCP
25GF Score
Cocrystal Pharma Inc COCP
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cocrystal Pharma OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Cocrystal Pharma's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-8.192 / 13.494536
=-60.71%

Cocrystal Pharma's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-2.34 * 4 / 13.92487
=-67.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -54.53 mean?
Cocrystal Pharma (COCP) has a OCF Yield % of -54.53 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cocrystal Pharma and its competitors. According to the industry distribution chart, Cocrystal Pharma ranks #1199 out of 1419 companies in the Biotechnology industry, placing it in the top 84.5%.
Is Cocrystal Pharma's OCF Yield % too high?
Cocrystal Pharma's current OCF Yield % is -54.53. Based on the distribution chart, Cocrystal Pharma ranks #1199 out of 1419 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Cocrystal Pharma has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cocrystal Pharma's OCF Yield % compare to OSRH and CVKD?
According to the Biotechnology industry distribution chart, Cocrystal Pharma ranks #1199 out of 1419 companies for OCF Yield %. This places Cocrystal Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cocrystal Pharma and its competitors. Cocrystal Pharma's current OCF Yield % is -54.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cocrystal Pharma stock overvalued right now?
Cocrystal Pharma (COCP) has a current OCF Yield % of -54.53. The current OCF Yield % is -54.53. Cocrystal Pharma's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Cocrystal Pharma (COCP), the current OCF Yield % is -54.53 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cocrystal Pharma Business Description

Other Exchanges 8CC:Germany
Address 19805 North Creek Parkway, Bothell, WA, USA, 98011
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
25GF Score

Get the complete analysis for COCP

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.01
Price